Search results
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
2 days ago · Backed by the size and reach of Johnson & Johnson, we are transforming lives and reinventing healthcare as we tackle society's most pressing health challenges. You can count on us to never stop working toward a future where disease is a thing of the past.
Jun 11, 2024 · We prioritize support for activities within Janssen’s areas of scientific interest that contribute to improved knowledge, practice and performance for healthcare providers and improved health outcomes for patients.
The Janssen COVID‑19 vaccine, sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, a subsidiary of American company Johnson & Johnson.
Jun 11, 2024 · Our Janssen CarePath coordinators can assist patients with answering questions about insurance coverage for our products and help identify options that may help make Janssen products more affordable, if needed. We also support healthcare providers by offering resources to support their patients.
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
The Janssen Pharmaceutical Companies of Johnson & Johnson. 1,024,765 followers. 9mo. We are advancing the discovery and development of therapies that deepen responses, remissions and hope in ...
Mar 3, 2021 · Learn more about the process of making a vaccine, and the ways Johnson & Johnson was able to partner and collaborate to manufacture the Janssen COVID-19 Vaccine.
Jul 30, 2020 · In January 2020, just as SARS-CoV-2, which causes COVID-19, began to spread around the globe, the Janssen Pharmaceutical Companies of Johnson & Johnson started researching potential vaccine candidates.
In 1961, Johnson & Johnson acquired Janssen Pharmaceutica, the innovative drug company and research lab focused on public health. The company was founded in 1953 by Belgian-born Dr. Paul Janssen, one of the century’s most creative and prolific drug developers.
